Home | Donate | Contact Us | Physicians | 1.888.STJOES1
Patient Care Services
Home - Programs of Excellence - Cardiac Services - CorPath Robotic Angioplasty - Is CorPath Robotic Angioplasty Right for Me?

Is CorPath Robotic Angioplasty Right for Me?

If your general cardiologist recommended you see an interventional cardiologist with training on the CorPath System, he or she probably feels this is a good option for you.

Only your interventional cardiologist can decide if CorPath Robotic Angioplasty (also known as robotic-assisted PCI) is right for you.

Does the robot really operate on me?

Think of the CorPath System as an extension of your interventional cardiologist’s hands, providing greater precision and placement of the guide wires and balloon/stent catheters.

How did my doctor learn how to use the CorPath System?

Your interventional cardiologist underwent extensive training to use the CorPath System. The CorPath System is a relatively simple intuitive system to learn how to use. Doctors are amazed by the precise movements that they can achieve. Further, the makers of the System designed the radiation-free cockpit ergonomically with your doctor’s comfort in mind. This results in a more focused doctor who experiences less eye, neck and back strain.

Have other people had CorPath Angioplasties?

The CorPath System is the only robotic-assisted PCI system cleared by the FDA. This means the System
had to undergo clinical trials in order for the FDA to clear it for use by interventional cardiologists in the United States.

One of the clinical trials evaluated the safety and effectiveness of the CorPath System in the delivery and manipulation of coronary guide wires and stent/balloon catheters for use in PCI procedures. 164 patients at nine clinical sites in the US and abroad participated in the study designed to evaluate CorPath System clinical and technical performance and compare it to a standard manual procedure.

What were the results of the study?

•  100 percent of subjects achieved post-procedure stenosis of <30 percentage (as evaluated by a
Core Laboratory)

•  No device-related complications observed

•  97.6 percent of subjects had an absence of in-hospital Major Adverse Cardiac Events (MACE).

•  98.8 percentage technical success rate (Two cases where physicians switched to manual)

•  Reduction in physician radiation exposure compared to exposure at the procedure table (95 percent)

•  Reduction in contrast media usage compared to historic data (Nikolsky, 2007)

Explore more:

•  About CorPath Robotic Angioplasty

Cardiac Services
Phone: 1-888-STJOES1
Emergency: 911